2
ABOUT Rx COMMUNICATIONS Specialists in the life science and health care industries Partner-driven -- Senior level counsel on EVERY account Navigate clients through up and down market cycles, various political health care agendas and technology trends

3
ABOUT Rx COMMUNICATIONS Experience with private and public companies – domestic and international Focused on what we do best: Investor Relations and Financial/Science Media Relations Strong Wall Street and media contacts Headquartered in New York City

5
WHY EMBARK ON AN IR/PR PROGRAM AS A PRIVATE COMPANY? Lay the groundwork for future financings and eventual IPO Assist with partnering activities by building corporate awareness Build awareness of disease indications to generate product interest Align company with reputable bankers Become accustomed to working within disclosure rules i.e., Reg. FD

18
THE Rx TEAM Eric Goldman, Vice President Six years with Rx Communications 25 years experience in public relations and as a media relations strategist specializing in biotechnology, health care, technology and consumer products Senior Director and Vice President at GlobalFluency Handled media relations at Spector & Associates and Brouillard Communications, a division of J. Walter Thompson Earned 2 Silver Anvil awards for public relations excellence

19
THE Rx TEAM Paula B. Schwartz, Senior Vice President Ten years with Rx Communications Partner, FRB/Weber Shandwick, oldest and largest Investor Relations firm in the U.S. Vice President, ECOM Consultants, Inc., an investor relations firm Vice President/Director of Investor Relations Programs, KCS&A Public Relations, a public relations and investor relations consultancy

22
OURx SUCCESSES Helped to grow Alexion Pharmaceuticals institutional shareholder base from 30% in 1996 to approximately 95% today. Launched not-for-profit Immune Tolerance Institute resulting in broad coverage in the U.S. including CBS Radio Network, San Francisco Business Times and Drug Discovery News. Garnered coverage for Catalyst Pharmaceutical Partners compound for cocaine addiction. Placements included cover stories in Newsweek, Scientific American Mind and NeuroInvestment.

23
OURx SUCCESSES Designed and implemented assertive investor outreach program for PDI which doubled trading volume and tripled its stock price within nine months. Arranged feature coverage focused on Hodgkins and non-Hodgkins lymphoma for MethylGene with Genetic Engineering News, Pink Sheet, BioCentury and Pharmawire Implemented aggressive IR program for PharmAthene, Inc. which enabled the company to obtain coverage from two new sell-side analysts, garner investments from four new institutional funds and increase trading volume by three-fold within nine months.

26
OURx SUCCESSES We are pleased to announce that Rx Communications has been selected by PR Week as a finalist for Boutique PR Agency of the Year Rx Communications was named Best Small PR Agency by League of American Communications Professionals Rx Communications Group was honored with the Stevie Award for Best Investor Relations Program for work on behalf of specialty pharmaceutical company, NexMed, Inc.

27
OURx SUCCESSES Rx Communications was honored with the SABRE Awards Certificate of Excellence for Building a North American Investor Base for client Syngenta AG. We are also pleased to share that our work for ImpactRx has won an Honorable Mention Award in LACPs (League of American Communications Professionals) Publicity Campaign Competition. Rx Communications received an honorable Mention Award from PR News, as part of the PR News Platinum PR Awards. The award was issued in the Financial/Investor Relations category, for the company's work on behalf of Genaissance Pharmaceuticals, Inc.

28
WHY Rx COMMUNICATIONS? Specialist industry knowledge and expertise Personal attention from Rx partners Decades of experience in strategic counsel and implementation of financial public relations programs Unique niche in working with private companies Well versed in IPOs, secondary offerings, PIPEs, venture rounds and mergers and acquisitions The Street knows and trusts us